期刊文献+

不同剂型硝苯地平对高血压患者血压及心率变异性的影响 被引量:11

下载PDF
导出
摘要 目的探讨不同剂型硝苯地平对高血压患者血压变异性、心率变异性的影响。方法将原发性高血压病146例随机分为心痛定治疗组45例、伲福达治疗组47例、拜新同治疗组54例;以健康查体血压正常的40例志愿者作为对照组。患者治疗前及治疗2周后于门诊或病房行同日动态血压、动态心电图监测,记录血压变异性指标(血压标准差)、心率变异性指标(SDANN、RMSSD、PNN50;LF、HF、LF/HF)。结果治疗前高血压患者血压变异性高于对照组(P<0.01)。治疗2周后,心痛定组收缩及舒张血压的变异性高于治疗前水平(P均<0.05),拜新同组收缩压的变异性低于治疗前水平(P<0.05)。治疗后伲福达组、拜新同组心率变异性时域性指标改善明显(P均<0.05);频域性指标心痛定组升高、拜新同组明显降低(P均<0.05),以上指标治疗后三组比较之间亦有统计学差异(P均<0.05)。SDNN与血压标准差、血压负荷值呈正相关(r分别为0.692、0.621,P均<0.05),LF/HF与血压标准差、血压负荷值呈负相关(r分别为-0.782、-0.664,P均<0.05)。结论长效硝苯地平在降低血压的同时,可以有效改善患者的血压、心率变异性。
出处 《山东医药》 CAS 2014年第17期35-37,共3页 Shandong Medical Journal
基金 潍坊市卫生局科研计划项目(2011-29)
  • 相关文献

参考文献7

  • 1Kohara K,Nishida W,Maguchi M.Autonomic nervous function in non dipper essential hypertensive subjects.Evaluation by power spectal analysis of HRV[J].Hypertension,1995,26(5):808-814.
  • 2Signh DS.Heart rate variability in systemic hypertension[J].Am J Cardiol,2001,93(7):1043.
  • 3Goldstein DS.Plasma catecholamines and essential hypertensiON:An analytical review[J].Hypertension,1983,5(3):86-89.
  • 4Petretta M,Canonico V,Madrid A,et al.Comparision of verapamil versus felodipine on heart rate variability in hypertensinve patients[J].J Hypertens,1999,17(5):707-713.
  • 5Huikuri HV,Ylitalo A,Pikkujamsa SM,et al.Heart rate variability in systemic hypertension[J].Am J Cardiol,1996,77(12):1073-1077.
  • 6顾薇,郑柏生,陈阳,宫玲,杨树平.硝苯地平控释片与氨氯地平对原发性高血压患者血压和心率变异性的影响[J].中国临床药学杂志,2001,10(1):9-11. 被引量:12
  • 7SzekacsB,Vajo Z,Acs N,et al.Hormone replacement therapy reduceds mean 24-hour blood pressure and its variability in postmenopausal women with treated hypertension[J].Menopause,2000,7(1):31-35.

二级参考文献1

共引文献11

同被引文献67

  • 1周磊,吕远,张小勇.硝苯地平联合依那普利治疗老年冠心病合并高血压的疗效[J].中国老年学杂志,2014,34(5):1389-1390. 被引量:43
  • 2刘小红.硝苯地平控释片联合缬沙坦治疗原发性高血压的效果观察[J].中国当代医药,2013,20(24):86-87. 被引量:17
  • 3苗迎春,张革萍.缬沙坦联合硝苯地平控释片治疗原发性高血压的临床疗效观察[J].环球中医药,2013,6(S2):146-146. 被引量:12
  • 4钟瑞琼,罗伟燕,童瑜,等.口服速尿对延缓肾衰竭期高血压良性小动脉性肾硬化症的疗效[J].医药前沿,2012,2(16):33-34.
  • 5Destro M,Luckow A,Samson M,et al.Efficacy and safety of am- lodipine/valsartan compared with amlodipine monotherapy in patients with stage 2 hypertension:a randomized,double-blind,multicenter study: the EX-EFFeCTS study[J].J Am Soc Hypertens, 2008,2(4) : 294-302.
  • 6Shimizu Y, yamasaki F, Furuno T, et al.Metabolic effect of com- bined telmisartan and nifedipine CR therapy in patients with essential hypertension[J].Int J Gen Med,2012(5):753-758.
  • 7Pringle E,Phillips C,Thijs L,et al.Systolic blood pressure variability as a risk factor for stroke and cardiovascular mortality in the elderlyhypertensive population[J].J Hypertens,2003,21(12):2251-2257.
  • 8Webb AJ,Fischer U,Mehta Z,et al.Effects of antihypertensivedrug class on interindividual variation in blood pressure and risk of stroke:asystematic review and meta-analysis[J].Lancet,2010,375(9718):906-915.
  • 9Jamerson K,Weber MA,Bakris GL,et al.Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients[J].N Engl J Med,2008,359(23):2417-2428.
  • 10Rothwell PM,Howard SC,Dolan E,et al.Prognostic significance of visit-to-visit variability,maximum systolic blood pressure,and episodic hypertension[J].Lancet,2010,375(9718):895-905.

引证文献11

二级引证文献84

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部